KI-SS web header 4

Professor Kevin V. Morris – Nanoparticle RNA therapeutics to treat viral infections and disease

Event date
Tuesday 6 February
Event time
1:00pm - 2:00pm
Event address
In-person & online. Kirby Institute, Seminar Room Level 6, Wallace Wurth Building, Kensington Campus, UNSW Sydney

RNA interference (RNAi) technology is a programmable, modular, scalable, and non-immunogenic approach to controlling gene expression based on endogenous mechanisms imbued in the human cell. In this seminar Professor Morris will provide examples of lipid nanoparticle and exosome mediated delivery of therapeutic RNAs to treat various human diseases.

Kevin V. Morris

Professor Kevin V. Morris

Professor, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology

Kevin V. Morris is an American-born Australian resident, scientist and corresponding author on over 140 peer-reviewed publications on RNA control of gene transcription, gene and cell therapies and innovative lipid nanoparticle and extracellular vesicle platforms for RNA drug delivery.


Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.